BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 33436555)

  • 1. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.
    Bhat AA; Yousuf P; Wani NA; Rizwan A; Chauhan SS; Siddiqi MA; Bedognetti D; El-Rifai W; Frenneaux MP; Batra SK; Haris M; Macha MA
    Signal Transduct Target Ther; 2021 Jan; 6(1):12. PubMed ID: 33436555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
    Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
    Front Immunol; 2021; 12():652054. PubMed ID: 34305889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immune microenvironment in head and neck cancers.
    Chen SMY; Krinsky AL; Woolaver RA; Wang X; Chen Z; Wang JH
    Mol Carcinog; 2020 Jul; 59(7):766-774. PubMed ID: 32017286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
    Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
    Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
    Zhu D; He X; Li Y; Li G; Chen M
    Sci Prog; 2024; 107(1):368504241237888. PubMed ID: 38545800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.
    Miyauchi S; Kim SS; Pang J; Gold KA; Gutkind JS; Califano JA; Mell LK; Cohen EEW; Sharabi AB
    Clin Cancer Res; 2019 Jul; 25(14):4211-4223. PubMed ID: 30814108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.
    Ruffin AT; Li H; Vujanovic L; Zandberg DP; Ferris RL; Bruno TC
    Nat Rev Cancer; 2023 Mar; 23(3):173-188. PubMed ID: 36456755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.
    Upadhyay R; Dhakal A; Wheeler C; Hoyd R; Jagjit Singh M; Karivedu V; Bhateja P; Bonomi M; Valentin S; Gamez ME; Konieczkowski DJ; Baliga S; Grecula JC; Blakaj DM; Gogineni E; Mitchell DL; Denko NC; Spakowicz D; Jhawar SR
    Cancer Biol Ther; 2024 Dec; 25(1):2350249. PubMed ID: 38722731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.
    Macha MA; Wani NA; Ganai RA; Bhat AA; Hamid A; Hashem S; Haris M; Chauhan SS; Zargar MA; Batra SK
    Adv Exp Med Biol; 2020; 1296():11-31. PubMed ID: 34185284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma.
    Seliger B; Massa C; Yang B; Bethmann D; Kappler M; Eckert AW; Wickenhauser C
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC.
    Gong X; Xiong J; Gong Y; Zhang J; Zhang J; Yang G; Chi H; Tian G
    Front Immunol; 2023; 14():1275270. PubMed ID: 37876923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
    Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
    Front Immunol; 2021; 12():645170. PubMed ID: 33897693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.
    An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y
    Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
    Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments.
    Outh-Gauer S; Morini A; Tartour E; Lépine C; Jung AC; Badoual C
    Head Neck Pathol; 2020 Jun; 14(2):330-340. PubMed ID: 32124416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and clinicopathological correlation of human papillomavirus in head and neck squamous cell carcinoma in India: A systematic review article.
    Nandi S; Mandal A; Chhebbi M
    Cancer Treat Res Commun; 2021; 26():100301. PubMed ID: 33401132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.